Apollo Medical Holdings, Inc. AMEH
We take great care to ensure that the data presented and summarized in this overview for Apollo Medical Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AMEH
View all-
Black Rock Inc. New York, NY6.38MShares$234 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$173 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$58.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$37.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX931KShares$34.2 Million0.01% of portfolio
-
Steel Peak Wealth Management LLC680KShares$25 Million1.11% of portfolio
-
325 Capital LLC New York, NY621KShares$22.8 Million9.97% of portfolio
-
North Crest Asset Manangement, LLC461KShares$16.9 Million0.53% of portfolio
-
Northern Trust Corp Chicago, IL426KShares$15.7 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA422KShares$15.5 Million0.0% of portfolio
Latest Institutional Activity in AMEH
Top Purchases
Top Sells
About AMEH
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Insider Transactions at AMEH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2024
|
Brandon Sim CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,626
-0.28%
|
$149,682
$57.87 P/Share
|
|
Sep 10
2024
|
Linda Marsh Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,522
-4.36%
|
$165,534
$47.93 P/Share
|
|
Sep 10
2024
|
Linda Marsh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+11.99%
|
$165,000
$15.35 P/Share
|
|
Sep 10
2024
|
Mitchell W Kitayama Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,522
-16.52%
|
$165,534
$47.93 P/Share
|
|
Sep 10
2024
|
Mitchell W Kitayama Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+34.04%
|
$165,000
$15.35 P/Share
|
|
Sep 09
2024
|
John Chiang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,565
-18.36%
|
$167,555
$47.35 P/Share
|
|
Sep 09
2024
|
John Chiang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+36.17%
|
$165,000
$15.35 P/Share
|
|
Sep 09
2024
|
Thomas S. Lam Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,046
-2.69%
|
$519,162
$47.35 P/Share
|
|
Sep 09
2024
|
Thomas S. Lam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,046
+6.4%
|
$504,828
$18.65 P/Share
|
|
Aug 16
2024
|
David Schmidt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,409
-60.74%
|
$706,041
$49.76 P/Share
|
|
Aug 14
2024
|
David Schmidt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,409
+23.85%
|
$230,544
$16.88 P/Share
|
|
Aug 13
2024
|
David Schmidt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+27.68%
|
-
|
|
Aug 13
2024
|
John Chiang Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+29.75%
|
-
|
|
Aug 13
2024
|
Dai, Weili Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+33.07%
|
-
|
|
Aug 13
2024
|
Mitchell W Kitayama Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+25.68%
|
-
|
|
Aug 13
2024
|
Linda Marsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+4.86%
|
-
|
|
Aug 13
2024
|
Matthew Mazdyasni Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+30.01%
|
-
|
|
Aug 01
2024
|
Dinesh M. Kumar Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
794
-0.53%
|
$40,494
$51.57 P/Share
|
|
Aug 01
2024
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
67
-0.37%
|
$3,417
$51.57 P/Share
|
|
Jul 11
2024
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
336
-1.8%
|
$15,120
$45.0 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 497K shares |
|---|---|
| Exercise of conversion of derivative security | 90.5K shares |
| Payment of exercise price or tax liability | 85.7K shares |
|---|---|
| Sale (or disposition) back to the issuer | 3.2M shares |